Chemomab Therapeutics Ltd...

NASDAQ: CMMB · Real-Time Price · USD
0.94
0.04 (4.76%)
At close: Aug 15, 2025, 3:58 PM
0.92
-1.59%
After-hours: Aug 15, 2025, 04:12 PM EDT

Chemomab Therapeutics Statistics

Share Statistics

Chemomab Therapeutics has 943.14K shares outstanding. The number of shares has increased by 31.36% in one year.

943.14K
31.36%
0.03%
1.15%
860.16K
2,646
1.73%

Short Selling Information

The latest short interest is 176.25K, so 0.93% of the outstanding shares have been sold short.

176.25K
0.93%
0.94%
1.41

Valuation Ratios

The PE ratio is -2330.15 and the forward PE ratio is -2.62. Chemomab Therapeutics's PEG ratio is 37.56.

-2330.15
-2.62
0
0
2.4
-2.11
37.56
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Chemomab Therapeutics.

n/a
n/a
n/a
n/a

Financial Position

The company has a current ratio of 4.98, with a Debt / Equity ratio of 0.02.

4.98
4.98
0.02
-22.08
-0.02
0

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

n/a
n/a
n/a
n/a
$-697.25
20
0
n/a

Taxes

n/a
0%

Stock Price Statistics

The stock price has increased by 0.42% in the last 52 weeks. The beta is 0.57, so Chemomab Therapeutics's price volatility has been higher than the market average.

0.57
0.42%
1.17
1.47
19.49
152,777

Income Statement

n/a
n/a
-14.74K
-13.95K
-14.67K
-14.74K
-0.78
Full Income Statement

Balance Sheet

The company has 6.07M in cash and 324K in debt, giving a net cash position of 5.75M.

6.07M
324K
5.75M
-102.62M
16.96M
12.82M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -15.46M and capital expenditures 0, giving a free cash flow of -15.39M.

-15.46M
n/a
-15.39M
-0.86
Full Cash Flow Statement

Margins

n/a
n/a
n/a
n/a
n/a
n/a
n/a

Dividends & Yields

CMMB does not appear to pay any dividends at this time.

n/a
n/a
n/a
n/a
n/a
n/a
Dividend Details

Analyst Forecast

The average price target for CMMB is $8.5, which is 794.7% higher than the current price. The consensus rating is "Strong Buy".

$8.5
794.7%
Strong Buy
2
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

n/a
n/a
n/a
n/a

Stock Splits

The last stock split was on Mar 17, 2021. It was a backward split with a ratio of 1:16.

Mar 17, 2021
backward
1:16

Scores

-10.17
1